Diabetes, Vol 46, Issue 12 1958-1964, Copyright © 1997 by American Diabetes Association

ARTICLES

Sensitization to insulin induced by beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) in obese Zucker rats in vivo

N Mayorek, B Kalderon, E Itach and J Bar-Tana
Department of Human Nutrition and Metabolism, Faculty of Medicine, The Hebrew University, Jerusalem, Israel.

Beta,beta'-methyl-substituted hexadecanedioic acid (MEDICA 16) consists of a nonmetabolizable long-chain fatty acid designed to probe the effect exerted by fatty acids on insulin sensitivity. The effect of MEDICA 16 was evaluated in insulin-resistant Zucker (fa/fa) rats in terms of liver, muscle, and adipose tissue response to clamped euglycemic hyperinsulinemia in vivo. Nontreated Zucker rats were insulin resistant, maintaining basal rates of total-body glucose disposal, glucose production in liver, free fatty acid (FFA) flux into plasma, and FFA reesterification in adipose tissue, irrespective of the insulin levels induced. MEDICA 16 treatment resulted in an insulin-induced decrease in hepatic glucose production, together with an insulin-induced increase in total-body glucose disposal. Intracellular reesterification of lipolysed FFA in adipose tissue was specifically activated by MEDICA 16, resulting in a pronounced decrease in FFA release, with a concomitant decrease in plasma FFA. In conclusion, MEDICA 16 treatment results in the sensitization of liver, muscle, and adipose tissue to insulin in an animal model for obesity-induced insulin resistance.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				G. Las, N. Mayorek, K. Dickstein, and J. Bar-Tana Modulation of Insulin Secretion by Fatty Acyl Analogs Diabetes, December 1, 2006; 55(12): 3478 - 3485. [Abstract] [Full Text] [PDF]

				B. Kalderon, N. Mayorek, L. Ben-Yaacov, and J. Bar-Tana Adipose tissue sensitization to insulin induced by troglitazone and MEDICA 16 in obese Zucker rats in vivo Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E795 - E803. [Abstract] [Full Text] [PDF]

				L. L. Atkinson, S. E. Kelly, J. C. Russell, J. Bar-Tana, and G. D. Lopaschuk MEDICA 16 Inhibits Hepatic Acetyl-CoA Carboxylase and Reduces Plasma Triacylglycerol Levels in Insulin-Resistant JCR: LA-cp Rats Diabetes, May 1, 2002; 51(5): 1548 - 1555. [Abstract] [Full Text] [PDF]

				B. Kalderon, N. Mayorek, E. Berry, N. Zevit, and J. Bar-Tana Fatty acid cycling in the fasting rat Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E221 - E227. [Abstract] [Full Text] [PDF]

				O. Hermesh, B. Kalderon, and J. Bar-Tana Mitochondria Uncoupling by a Long Chain Fatty Acyl Analogue J. Biol. Chem., February 13, 1998; 273(7): 3937 - 3942. [Abstract] [Full Text] [PDF]

				M. Guerre-Millo, P. Gervois, E. Raspe, L. Madsen, P. Poulain, B. Derudas, J.-M. Herbert, D. A. Winegar, T. M. Willson, J.-C. Fruchart, et al. Peroxisome Proliferator-activated Receptor alpha Activators Improve Insulin Sensitivity and Reduce Adiposity J. Biol. Chem., May 26, 2000; 275(22): 16638 - 16642. [Abstract] [Full Text] [PDF]